American Journal of Kidney Diseases
Volume 52, Issue 1 , Pages 144-153 , July 2008

A Review of Drug-Induced Hyponatremia

  • George Liamis, MD
    • ,
  • Haralampos Milionis, MD
    • ,
  • Moses Elisaf, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Moses Elisaf, MD, Professor of Medicine, Department of Internal Medicine, School of Medicine, University of Ioannina, 45110 Ioannina, Greece.

Received 13 November 2007 ,Accepted 3 March 2008.

References 

  1. Anderson RJ, Chung HM, Kluge R, Schrier RW. Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med. 1985;102:164–168
  2. Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: Correlation with brain water and electrolytes. Medicine (Baltimore). 1976;55:121–129
  3. Gross PA, Ketteler M, Hausmann C, Ritz E. The chartered unchartered waters of hyponatremia. Kidney Int Suppl. 1987;21:S67–S75
  4. Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med. 1986;314:1529–1535
  5. Berl T. Treating hyponatremia: Damned if we do and damned if we don't. Kidney Int. 1990;37:1006–1018
  6. Ellis SJ. Severe hyponatraemia: Complications and treatment. QJM. 1995;88:905–909
  7. Lauriat SM, Berl T. The hyponatremic patient: Practical focus on therapy. J Am Soc Nephrol. 1997;8:1599–1607
  8. Spital A. Diuretic-induced hyponatremia. Am J Nephrol. 1999;19:447–452
  9. Byatt CM, Millard PH, Levin GE. Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. J R Soc Med. 1990;83:704–708
  10. Liamis G, Christidis D, Alexandridis G, Bairaktari E, Madias N, Elisaf M. Uric acid homeostasis in the evaluation of diuretic-induced hyponatremia. J Investig Med. 2007;55:36–44
  11. Friedman E, Shadel M, Halkin H, Farfel Z. Thiazide-induced hyponatremia (Reproducibility by single dose rechallenge and an analysis of pathogenesis). Ann Intern Med. 1989;110:24–30
  12. Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med. 1981;70:1163–1168
  13. Ashouri OS. Severe diuretic-induced hyponatremia in the elderly. A series of eight patients: Arch Intern Med. 1986;146:1355–1357
  14. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia (Review and analysis of 129 reported patients). Chest. 1993;103:601–606
  15. Abramow M, Cogan E. Clinical aspects and pathophysiology of diuretic-induced hyponatremia. Adv Nephrol Necker Hosp. 1984;13:1–28
  16. Clark BA, Shannon RP, Rosa RM, Epstein FH. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol. 1994;5:1106–1111
  17. Pinnock CA. Hyponatraemia associated with hydrochrorothiazide treatment. Br Med J. 1978;1:48–54
  18. Dyckner T, Wester PO. Effects of magnesium infusions in diuretic induced hyponatraemia. Lancet. 1981;1(8220):585–586
  19. Chapman M, Hanrahan R, McEwen J, Marley J. Hyponatremia and hypokalemia due to indapamide. MJA. 2002;176:219–221
  20. Luzecky MH, Burman KD, Schultz ER. The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration. South Med J. 1974;67:495–497
  21. ten Holt WL, van Iperen CE, Schrijver G, Bartelink A. Severe hyponatremia during therapy with fluoxetine. Arch Intern Med. 1996;156:681–682
  22. Jackson C, Carson W, Markowitz J, Mintzer J. SIADH associated with fluoxetine and sertraline therapy. Am J Psychiatry. 1995;152:809–810
  23. Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: A review of spontaneous reports. CMAJ. 1996;155:519–527
  24. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006;40:1618–1622
  25. Movig KL, Leufkens HG, Lenderink AW, et al. Association between antidepressant drugs and hyponatremia: A case-control study. Br J Clin Pharmacol. 2002;53:363–369
  26. Peterson JC, Pollack RW, Mahoney JJ, Fuller TJ. Inappropriate antidiuretic hormone secondary to a monamine oxidase inhibitor. JAMA. 1978;239:1422–1423
  27. Vincent FM, Emery S. Antidiuretic hormone syndrome and thioridazine. Ann Intern Med. 1978;89:147–148
  28. Rao KJ, Miller M, Moses A. Water intoxication and thioridazine (Mellaril). Ann Intern Med. 1975;82:61
  29. Peck V, Shenkman L. Haloperidol-induced syndrome of inappropriate secretion of antidiuretic hormone. Clin Pharmacol Ther. 1979;26:442–444
  30. Meinders AE, Cejka V, Robertson GL. The antidiuretic action of carbamazepine in man. Clin Sci Mol Med. 1974;47:289–299
  31. Gold PW, Robertson GL, Ballenger JC, et al. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab. 1983;57:952–957
  32. Flegel KM, Cole CH. Inappropriate antidiuresis during carbamazepine treatment. Ann Intern Med. 1977;87:722–723
  33. Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: A review. Epilepsia. 1994;35:181–188
  34. Kuz GM, Manssourian A. Carbamazepine-induced hyponatremia: Assessment of risk factors. Ann Pharmacother. 2005;39:1943–1946
  35. Holtschmidt-Taschner B, Soyka M. Hyponatremia-induced seizure during carbamazepine treatment. World J Biol Psychiatry. 2007;8:51–53
  36. Dong X, Leppik IE, White J, Rarick J. Hyponatremia from oxcarbazepine and carbamazepine. Neurology. 2005;65:1976–1978
  37. Nielsen OA, Johannessen AC, Bardrum B. Oxcarbazepine-induced hyponatremia, A cross-sectional study. Epilepsy Res. 1988;2:269–271
  38. Ikeda K, Moriyasu H, Yasaka M, Oita J, Yamaguchi T. Valproate related syndrome of inappropriate secretion of antidiuretic hormone (SIADH)—A case report. Rinsho Shinkeigaku. 1994;34:911–913
  39. Robertson GL, Bhoopalam N, Zelkowitz LJ. Vincristine neurotoxicity and abnormal secretion of antidiuretic hormone. Arch Intern Med. 1973;132:717–720
  40. RaviKumar TS, Grage TB. The syndrome of inappropriate antidiuretic hormone secretion secondary to vinblastine-bleomycin therapy. J Surg Oncol. 1983;24:242–245
  41. Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer. 2007;15:1341–1347
  42. Berghmans T. Hyponatremia related to medical anticancer treatment. Support Care Cancer. 1996;4:341–350
  43. Lee YK, Shin DM. Renal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancer. Korean J Intern Med. 1992;7:118–121
  44. Giaccone G, Donadio M, Ferrati P, et al. Disorders of serum electrolytes and renal function in patients treated with cis-platinum on an outpatient basis. Eur J Cancer Clin Oncol. 1985;21:433–437
  45. DeFronzo RA, Braine H, Colvin M, Davis PJ. Water intoxication in man after cyclophosphamide therapy (Time course and relation to drug activation). Ann Intern Med. 1973;78:861–869
  46. Bressler RB, Huston DP. Water intoxication following moderate-dose intravenous cyclophosphamide. Arch Intern Med. 1985;145:548–549
  47. Harlow PJ, DeClerck YA, Shore NA, Ortega JA, Carranza A, Heuser E. A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy. Cancer. 1979;44:896–898
  48. Greenbaum-Lefkoe B, Rosenstock JG, Belasco JB, Rohrbaugh TM, Meadows AT. Syndrome of inappropriate antidiuretic hormone secretion (A complication of high-dose intravenous melphalan). Cancer. 1985;55:44–46
  49. Culine S, Ghosn M, Droz JP. Inappropriate antidiuretic hormone secretion induced by ifosfamide. Eur J Cancer. 1990;26:922
  50. Frahm H, von Hulst M. Increased secretion of vasopressin and edema formation in high dosage methotrexate therapy. Z Gesamte Inn Med. 1988;43:411–414
  51. Langfeldt LA, Cooley ME. Syndrome of inappropriate antidiuretic hormone secretion in malignancy: Review and implications for nursing management. Clin J Oncol Nurs. 2003;7:425–430
  52. Mewasingh L, Aylett S, Kirkham F, Stanhope R. Hyponatraemia associated with lamotrigine in cranial diabetes insipidus. Lancet. 2000;356:656
  53. Weissman PN, Shenkman L, Gregerman RI. Chlorpropamide hyponatremia: Drug-induced inappropriate antidiuretic-hormone activity. N Engl J Med. 1971;284:65–71
  54. Kadowaki T, Hagura R, Kajinuma H, Kuzuya N, Yoshida S. Chlorpropamide-induced hyponatremia: Incidence and risk factors. Diabetes Care. 1983;6:468–471
  55. Moses AM, Fenner R, Schroeder ET, Coulson R. Further studies on the mechanism by which chlorpropamide alters the action of vasopressin. Endocrinology. 1982;111:2025–2030
  56. Moses AM, Howanitz J, Miller M. Diuretic action of three sulfonylurea drugs. Ann Intern Med. 1973;78:541–544
  57. Petersson I. Water intoxication associated with nonsteroidal anti-inflammatory drug therapy. Acta Med Scand. 1987;221:221–228
  58. Webberley MJ, Murray JA. Life-threatening acute hyponatremia induced by low dose cyclophosphamide and indomethacin. Postgrad Med J. 1989;65:950–955
  59. Page AJ, Reid SA, Speedy DB, Mulligan GP, Thompson J. Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflammatory drug use in an ultraendurance mountain run. Clin J Sport Med. 2007;17:43–48
  60. Almond CS, Shin AY, Fortescue EB, et al. Hyponatremia among runners in the Boston Marathon. N Engl J Med. 2005;352:1550–1556
  61. Ranieri P, Franzoni S, Rozzini R, Trabucchi M. Venlafaxine-induced reset osmostat syndrome: Case of a 79-year-old depressed woman. J Geriatr Psychiatry Neurol. 1997;10:75–78
  62. Izzedine H, Fardet L, Launay-Vacher V, Dorent R, Petitclerc T, Deray G. Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: Case report and review of the literature. Clin Pharmacol Ther. 2002;71:503–507
  63. Malaterre HR, Kallee K, Daver LM. Hyponatremia and amlodipine therapy. Cardiovasc Drugs Ther. 1999;13:171–172
  64. Palevsky PM, Rendulic D, Diven WF. Maltose-induced hyponatremia. Ann Intern Med. 1993;118:526–528
  65. Daphnis E, Stylianou K, Alexandrakis M, et al. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy. Nephron Clin Pract. 2007;106:c143–c148
  66. Holden R, Jackson MA. Near-fatal hyponatremic coma due to vasopressin over-secretion after “ecstasy” (3,4-MDMA). Lancet. 1996;347:1052
  67. Wilkins B. Cerebral oedema after MDMA (“ecstasy”) and unrestricted water intake (Hyponatraemia must be treated with low water input). BMJ. 1996;313:689–690
  68. Mori H, Kuroda Y, Imamura S, et al. Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole. Intern Med. 2003;42:665–669
  69. Adler D, Voide C, Thorens JB, Desmeules J. SIADH consecutive to ciprofloxacin intake. Eur J Intern Med. 2004;15:463–464
  70. Mitra S, Basu S. Cefoperazone/sulbactam induced hyponatremia. Indian J Med Sci. 2006;60:158–159
  71. Chitre MM, Berenson CS. Idiosyncratic rifabutin-induced leukopenia and SIADH: Case report and review. Pharmacotherapy. 2001;21:493–497
  72. Shavit E, Sherer Y. Hyponatremia induced by amiodarone therapy. Isr Med Assoc J. 2007;9:564–565
  73. Somani P, Temesy-Armos PN, Leighton RF, Goodenday LS, Fraker TD. Hyponatremia in patients treated with lorcainide, a new antiarrhythmic drug. Am Heart J. 1984;108:1443–1448
  74. Dirix LY, Moeremans C, Fierens H, et al. Symptomatic hyponatremia related to the use of propafenone. Acta Clin Belg. 1988;43:143–145
  75. Liberopoulos E, Alexandridis G, Christidis D, Elisaf M. SIADH and hyponatremia with theophylline. Ann Pharmacother. 2002;36:1180–1182
  76. Brewster UC, Perazella MA. Proton pump inhibitors and the kidney: Critical review. Clin Nephrol. 2007;68:65–72
  77. Marshall AW, Jakobovits AW, Morgan MY. Bromocriptine-associated hyponatraemia in cirrhosis. Br Med J. 1982;285:1534–1535
  78. Douriez E, Mollard P, Laval C, Albengres E, Laporte JP, Tillement JP. Severe hyponatremia after repeated administration of terlipressin. Therapie. 1993;48:518–519
  79. Kruger S, Lindstaedt M. Duloxetine and hyponatremia: A report of 5 cases. J Clin Psychopharmacol. 2007;27:101–104
  80. Ori Y, Korzets A, Bergman M, Vishelesky G, Salman H. Hyponatremia after fluorescein angiography. J Am Geriatr Soc. 2006;54:872–874
  81. Bagley SC, Yaeger D. Hyponatremia associated with bupropion, a case verified by rechallenge. J Clin Psychopharmacol. 2005;25:98–99
  82. Johnston C, Webb L, Daley J, Spathis GS. Hyponatraemia and moduretic-grand mal seizures: A review. J R Soc Med. 1989;82:479–483
  83. Sonnenblick M, Rosin AJ. Significance of the measurement of uric acid fractional clearance in diuretic induced hyponatremia. Postgrad Med J. 1986;62:449–452
  84. Decaux G, Schlesser M, Coffernils M, et al. Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol. 1994;42:102–108
  85. Raskind MA, Orenstein H, Christopher TG. Acute psychosis, increased water ingestion, and inappropriate antidiuretic hormone secretion. Am J Psychiatry. 1975;132:907–910
  86. Jose CJ, Perez-Cruet J. Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am J Psychiatry. 1979;136:221–222
  87. Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry. 1988;145:675–683
  88. Gin H, Lars I, Beauvieux JM, Morlat P, Aubertin J. Hyponatremia induced by biguanides (Case report). Presse Med. 1988;17:591
  89. Pittman JG. Water intoxication due to oxytocin. N Engl J Med. 1963;268:481
  90. Schwartz RH, Jones RW. Transplacental hyponatraemia due to oxytocin. Br Med J. 1978;1(6106):152–153
  91. Feeney JG. Water intoxication and oxytocin. Br Med J. 1982;285:243
  92. Shepherd LL, Hutchinson RJ, Worden EK, Koopmann CF, Coran A. Hyponatremia and seizures after intravenous administration of desmopressin acetate for surgical hemostasis. J Pediatr. 1989;114:470–472
  93. Humphries JE, Siragy H. Significant hyponatremia following DDAVP administration in a healthy adult. Am J Hematol. 1993;44:12–15
  94. Liamis G, Kalogirou M, Saugos V, Elisaf M. Therapeutic approach in patients with dysnatraemias. Nephrol Dial Transplant. 2006;21:1564–1569

 Originally published online as doi:10.1053/j.ajkd.2008.03.004 on May 8, 2008.

PII: S0272-6386(08)00574-X

doi: 10.1053/j.ajkd.2008.03.004

American Journal of Kidney Diseases
Volume 52, Issue 1 , Pages 144-153 , July 2008

Article Tools